BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14960260)

  • 1. Collaborative study for establishment of a global standard for the potency assay of human anti-D immunoglobulin.
    Thorpe SJ; Sands D; Fox B; Schäffner G; Yu MW; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):9-26. PubMed ID: 14960260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A global standard for anti-D immunoglobulin: international collaborative study to evaluate a candidate preparation.
    Thorpe SJ; Sands D; Fox B; Behr-Gross ME; Schäffner G; Yu MW
    Vox Sang; 2003 Nov; 85(4):313-21. PubMed ID: 14633258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
    Stickings P; Rigsby P; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
    Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
    Fuchs F; Minor P; Daas A; Milne C
    Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative study for the establishment of the Ph. Eur. BRP batch 1 for anti-vaccinia immunoglobulin.
    Fuchs F; Poirier B; Leparc-Goffart I; Buchheit KH
    Pharmeuropa Bio; 2005 Sep; 2005(1):13-8. PubMed ID: 16336934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
    Buchheit KH; Daas A; Stalder J
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of the European Pharmacopoeia Biological Reference Preparation (Ph. Eur. BRP) for hepatitis A vaccine type B (Aventis Pasteur) batch 2.
    Buchheit KH; Daas A
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):95-108. PubMed ID: 12448033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).
    Stalder J; Costanzo A; Daas A; Rautmann G; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
    Morgeaux S; Chagnaud P; Variot P; Le Tallec D; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2020; 2020():161-202. PubMed ID: 32788038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Pharmacopoeia biological reference preparation for poliomyelitis vaccine (inactivated): collaborative study for the establishment of batch No. 3.
    Martin J; Daas A; Milne C
    Pharmeur Bio Sci Notes; 2016; 2016():135-150. PubMed ID: 28279255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of European Pharmacopoeia (Ph. Eur.) Biological Reference Preparations (BRP) batch 2 for rDNA hepatitis B vaccine (method A and B).
    Dobbelaer R; Daas A; Milne C
    Pharmeuropa Bio; 2004 Jan; 2003(2):77-90. PubMed ID: 14960264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
    Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of replacement batches for prekallikrein activator in albumin biological reference preparation.
    Lackner F; Daas A; Terao E; Behr-Gross ME
    Pharmeuropa Bio; 2008 Dec; 2008(1):1-6. PubMed ID: 19220976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative study for the establishment of replacement batches for human coagulation factor IX concentrate reference standards.
    Gray E; Pickering W; Hockley J; Rigsby P; Weinstein M; Terao E; Buchheit KH
    Pharmeuropa Bio; 2008 Dec; 2008(1):19-30. PubMed ID: 19220978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique.
    Nübling CM; Daas A; Buchheit KH
    Pharmeuropa Bio; 2004 Jan; 2003(2):27-34. PubMed ID: 14960261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.